Upregulation of HARP during in vitro myogenesis and rat soleus muscle regeneration.

Authors: Caruelle, D  Mazouzi, Z  Husmann, I  Delbe, J  Duchesnay, A  Gautron, J  Martelly, I  Courty, J 
Citation: Caruelle D, etal., J Muscle Res Cell Motil. 2004;25(1):45-53.
Pubmed: (View Article at PubMed) PMID:15160487

Heparin affin regulatory peptide (HARP) is a heparin binding growth factor that belongs to a family of molecule whose biological function in myogenesis has been suspected without formal demonstration. In the present study, we investigated the expression and the distribution of HARP and its mRNA during soleus muscle regeneration using a crushed-induced regeneration model and also during differentiation of muscle satellite cells in primary cultures. We show that HARP mRNA and protein expression are increased during the regeneration process with a peak at day 5 after muscle crushing when new myotubes are formed. In situ hybridization and immunohistochemical studies showed that activated myoblasts expressed HARP at day two after crushing. Five days after muscle lesion, HARP is localised in newly formed myotubes as well as in prefused activated myoblasts. In regenerated myofibers, 15 days after crushing, expression of HARP was reduced. In vitro experiments using primary cultures of rat satellite cells indicated that HARP expression level increased during the differentiation process and peaked on fusion of myoblasts into myotubes. This is the first study demonstrating the presence of HARP in fusing myogenic cells suggests that this growth factor could play a function in myogenic differentiation.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 10044016
Created: 2015-06-01
Species: All species
Last Modified: 2015-06-01
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.